Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01582191
Recruitment Status : Recruiting
First Posted : April 20, 2012
Last Update Posted : August 2, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center